A team from the Seattle Children's Therapeutics Development Network (TDN) Coordinating Center conducted a survey to assess the need for researchers to evaluate withdrawal of gastrointestinal medications for people with CF on highly effective modulators. Results from this survey are currently being presented to members of the TDN, Clinical Research Scholars Program, and CF Foundation. A key finding revealed that there is a need to design studies that focus on simplifying regimens for acid suppression and pancreatic enzyme replacement therapy for those on highly effective modulators. This finding is also informing a potential new study that will help determine how to safely decrease/stop acid suppressive medication while optimizing time constraints. Thank you to all who participated in the survey, and please stay tuned for an update on this project in the future!